116 filings
Page 4 of 6
8-K
gnb 0w4dmvcmwni
14 Jan 20
Targeting Pruritus with Novel Peripherally - Restricted Kappa Agonist Therapeutics JP Morgan Healthcare Conference January 2020
8:00am
8-K
q8pjdei
23 Dec 19
Departure of Directors or Certain Officers
8:00am
8-K
jxwp8xs
16 Dec 19
Regulation FD Disclosure
6:05am
8-K
j8oers
3 Dec 19
Regulation FD Disclosure
9:15am
8-K
e0l0jkhjmtvbuq9u9f1c
20 Nov 19
Other Events
4:10pm
8-K
bsog9owy96bq
5 Nov 19
Cara Therapeutics Reports Third Quarter 2019 Financial Results
4:05pm
8-K
miuc5swwued6ce2
21 Aug 19
Entry into a Material Definitive Agreement
8:02am
8-K
gvutw l5g7rthuc
7 Aug 19
Cara Therapeutics Reports Second Quarter 2019 Financial Results
4:12pm
8-K
qj73gxrhfxq1m ognwy
29 Jul 19
Cara Therapeutics Announces Pricing of $126.5 Million Offering of Common Stock
4:11pm
8-K
p67jw7q8jbf38 op5bd
24 Jul 19
Cara Therapeutics Announces Proposed Offering of Common Stock
4:15pm
8-K
1hm7 xe2wrl8
12 Jul 19
Entry into a Material Definitive Agreement
4:10pm
8-K
cy2hf3e1 e0m3479pqgc
5 Jun 19
Submission of Matters to a Vote of Security Holders
5:19pm
8-K
v7ciov403ixi9pp
29 May 19
Cara Therapeutics Announces Positive Results From
7:17am
8-K
vv68l1gfbdcav
7 May 19
Cara Therapeutics Reports First Quarter 2019 Financial Results
4:10pm
8-K
b5oahl 25dyof0t8fffu
12 Mar 19
Cara Therapeutics Reports Fourth Quarter and Full Year 2018
4:10pm
8-K
7dujfji8
6 Nov 18
Cara Therapeutics Reports Third Quarter 2018 Financial Results
4:11pm
8-K
u580g55e iqvzn
23 Oct 18
Departure of Directors or Certain Officers
7:29am
8-K
pltkdvg
7 Aug 18
Cara Therapeutics Reports Second Quarter 2018 Financial Results
4:11pm
8-K
e3f0 eakknxgd51umxt
6 Aug 18
Departure of Directors or Certain Officers
4:10pm
8-K
tu1rkur5 dfti
23 Jul 18
Cara Therapeutics Announces Pricing of $85.5 Million Offering of Common Stock
4:10pm